IRIS
DE STEFANO, NICOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 26.964
EU - Europa 18.332
AS - Asia 3.982
SA - Sud America 67
AF - Africa 44
OC - Oceania 43
Continente sconosciuto - Info sul continente non disponibili 24
Totale 49.456
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 26.900
GB - Regno Unito 6.141
IE - Irlanda 3.146
CN - Cina 2.316
UA - Ucraina 1.979
IT - Italia 1.466
RU - Federazione Russa 1.316
SE - Svezia 1.314
FR - Francia 1.030
DE - Germania 937
SG - Singapore 658
HK - Hong Kong 652
FI - Finlandia 503
ES - Italia 128
VN - Vietnam 117
BE - Belgio 88
TR - Turchia 77
NL - Olanda 67
CA - Canada 56
BR - Brasile 48
AU - Australia 34
CZ - Repubblica Ceca 32
IN - India 30
RO - Romania 27
CI - Costa d'Avorio 25
MK - Macedonia 25
JP - Giappone 24
EU - Europa 23
IR - Iran 23
PH - Filippine 20
AT - Austria 19
IL - Israele 17
CH - Svizzera 14
RS - Serbia 14
GR - Grecia 12
BG - Bulgaria 10
NZ - Nuova Zelanda 9
HU - Ungheria 8
MD - Moldavia 8
PL - Polonia 8
AR - Argentina 7
CL - Cile 6
EG - Egitto 6
LU - Lussemburgo 6
MA - Marocco 6
KR - Corea 5
KZ - Kazakistan 5
NO - Norvegia 5
PT - Portogallo 5
SA - Arabia Saudita 5
ID - Indonesia 4
MX - Messico 4
PK - Pakistan 4
ZA - Sudafrica 4
AL - Albania 3
DK - Danimarca 3
HR - Croazia 3
LK - Sri Lanka 3
LT - Lituania 3
PA - Panama 3
TH - Thailandia 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BD - Bangladesh 2
BN - Brunei Darussalam 2
BY - Bielorussia 2
CO - Colombia 2
EC - Ecuador 2
EE - Estonia 2
IM - Isola di Man 2
LV - Lettonia 2
NP - Nepal 2
SI - Slovenia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
CR - Costa Rica 1
CY - Cipro 1
DZ - Algeria 1
FK - Isole Falkland (Malvinas) 1
IS - Islanda 1
JO - Giordania 1
KE - Kenya 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
MM - Myanmar 1
MN - Mongolia 1
MY - Malesia 1
PE - Perù 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
UZ - Uzbekistan 1
Totale 49.456
Salva come PNG Salva come JPEG
Città #
Southend 5.637
Fairfield 4.003
Dublin 3.132
Houston 3.030
Chandler 1.954
Ashburn 1.942
Woodbridge 1.917
Jacksonville 1.653
Wilmington 1.583
Seattle 1.561
Cambridge 1.390
Menlo Park 1.283
Santa Clara 1.013
Princeton 752
Ann Arbor 708
Nanjing 558
Siena 488
Beijing 439
Singapore 417
Boardman 273
San Mateo 258
San Diego 215
Nanchang 209
Helsinki 178
Shenyang 162
Málaga 117
Dong Ket 113
Norwalk 109
Moscow 104
Tianjin 95
Hebei 94
New York 93
Florence 80
Changsha 78
Jiaxing 77
Milan 76
Kunming 75
Lancaster 75
Düsseldorf 74
London 70
Dearborn 68
Brussels 67
Falls Church 61
Jinan 59
Izmir 53
Shanghai 50
Rome 46
Hangzhou 45
San Francisco 38
Zhengzhou 38
Ningbo 35
Guangzhou 34
Toronto 33
Los Angeles 31
Fremont 29
Venezia 26
Washington 26
Abidjan 25
Amsterdam 25
Kilburn 22
Lanzhou 22
Pisa 21
Taizhou 21
Tappahannock 21
Edinburgh 20
Munich 20
Frankfurt am Main 18
Hong Kong 18
Renton 18
Brno 17
Central 16
Changchun 16
Redwood City 16
Vienna 15
Haikou 14
Hefei 14
Lucca 14
Belgrade 13
Hounslow 13
Phoenix 13
Skopje 13
Stockholm 13
Chicago 12
Mestre 12
Sarzana 12
Melbourne 11
Turin 11
Bologna 10
Bonndorf 10
Chiswick 10
Indiana 10
Lappeenranta 10
Livorno 10
Messina 10
Waanrode 10
Bari 9
Canberra 9
Catania 9
Cedar Knolls 9
Padova 9
Totale 37.445
Salva come PNG Salva come JPEG
Nome #
Effect of fingolimod on diffuse brain tissue damage in relapsing-remitting multiple sclerosis patients 733
Choline is increased in pre-lesional normal appearing white matter in multiple sclerosis. 516
Imaging distribution and frequency of cortical lesions in patients with multiple sclerosis 404
Combined MRI lesions and relapses as a surrogate for disability in multiple sclerosis 389
Hemodynamic evaluation of the optic nerve head in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. 308
Neocortical volume decrease in relapsing-remitting multiple sclerosis with mild cognitive impairment 301
A novel NOTCH3 frameshift deletion and mitochondrial abnormalities in a patient with CADASIL 287
Development and psychometric properties of a neuropsychological battery for mild cognitive impairment with small vessel disease: The VMCI-tuscany study 232
The role of dentate nuclei in human oculomotor control: Insights from cerebrotendinous xanthomatosis 224
Appraisal of brain connectivity in radiologically isolated syndrome by modeling imaging measures 220
The burden of microstructural damage modulates cortical activation in elderly subjects with MCI and leuko-araiosis. A DTI and fMRI study 212
Relevance of cognitive deterioration in early relapsing-remitting MS: a 3-year follow-up study 211
Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) as a model of small vessel disease: Update on clinical, diagnostic, and management aspects 211
Systemic blood pressure profile in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy 196
Reliability, practice effects, and change indices for Rao's Brief Repeatable Battery. 196
SIENA-XL for improving the assessment of gray and white matter volume changes on brain MRI 194
Toscana itaca (Italian CADASIL) registry: an implementable online database for CADASIL (Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy). 192
Optimizing parameter choice for FSL-Brain Extraction Tool (BET) on 3D T1 images in multiple sclerosis 190
Diffuse brain damage in normal tension glaucoma 190
Chemical pathology of acute demyelinating lesions and its correlation with disability 187
A new missense mutation in caveolin-3 gene causes rippling muscle disease. 186
Voxel-wise assessment of progression of regional brain atrophy in relapsing-remitting multiple sclerosis 186
null 182
Vitamin E deficiency secondary to chronic intestinal malabsorption and effect of vitamin supplement: a case report 182
Primary Progressive Multiple Sclerosis Evolving from Radiologically Isolated Syndrome 180
Long-term assessment of no evidence of disease activity in relapsing-remitting MS 179
Connectivity-based parcellation of the thalamus in multiple sclerosis and its implications for cognitive impairment: A multicenter study 179
Reduced brain atrophy rates are associated with lower risk of disability progression in patients with relapsing multiple sclerosis treated with cladribine tablets. 179
Gray matter atrophy cannot be fully explained by white matter damage in patients with MS 179
The spectrum of magnetic resonance findings in cerebrotendinous xanthomatosis: redefinition and evidence of new markers of disease progression 176
A Rett syndrome MECP2 mutation that causes mental retardation in men 175
A semiautomatic method for multiple sclerosis lesion segmentation on Dual-Echo MR imaging: Application in a multicenter context 175
Cortical damage in brains of patients with adult-form of myotonic dystrophy type 1 and no or minimal MRI abnormalities 175
Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes 172
Relevance of brain lesion location to cognition in relapsing multiple sclerosis 172
Fingolimod effect on brain volume loss independently contributes to its effect on disability 171
Establishing pathological cut-offs of brain atrophy rates in multiple sclerosis 170
DTI-derived indexes of brain WM correlate with cognitive performance in vascular MCI and small-vessel disease. A TBSS study 170
Optic atrophy in Marinesco-Sjögren syndrome: an additional ocular feature. Report of three cases in two families 169
Evidence of diffuse damage in frontal and occipital cortex in the brain of patients with post-traumatic stress disorder 169
Spinal cord involvement in multiple sclerosis and neuromyelitis optica spectrum disorders 169
Progression of regional grey matter atrophy in multiple sclerosis 168
Structural and functional brain changes beyond visual system in patients with advanced glaucoma 168
Acute unilateral visual loss as the first symptom of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy 167
Combined aerobic training and dichloroacetate improve exercise capacity and indices of aerobic metabolism in muscle cytochrome oxidase deficiency 167
Cortical lesions in radiologically isolated syndrome. 166
A novel approach with “skeletonised MTR” measures tract-specific microstructural changes in early primary-progressive MS 166
A new family with CADASIL: presentation of an homozygous patient and comparison with heterozigous phenotypes. 165
Relationship between brain MRI lesion load and short-term disease evolution in non-disabling MS: A large-scale, multicentre study 164
Prognostic biomarkers of IFNb therapy in multiple sclerosis patients 164
Structural and metabolic damage in brains of patients with SPG11-related spastic paraplegia as detected by quantitative MRI 164
Twelve-year monitoring of a patient with megalencephalic leukoencephalopathy with subcortical cysts 163
MRI in Leber's hereditary optic neuropathy: the relationship to multiple sclerosis. 161
Impairment of muscle mitochondrial oxidative metabolism in McArdles's disease 161
Early structural changes in individuals at risk of familial Alzheimer's disease. A volumetry and magnetization transfer MR imaging study 161
[(11)C]PBR28 or [(18)F]PBR111 detect white matter inflammatory heterogeneity in multiple sclerosis 161
Validating the use of brain volume cutoffs to identify clinically relevant atrophy in RRMS 160
Clinical Course of Two Italian Siblings with Ataxia-Telangiectasia-Like Disorder. 160
Clinical relevance of brain volume changes in patients with cerebrotendinous xanthomatosis 159
Pathogenesis of multiple sclerosis: Insights from molecular and metabolic imaging 159
Early changes of brain connectivity in primary open angle glaucoma 159
Blood–brain barrier permeability in a patient with Labrune syndrome due to SNORD118 mutations 158
Brain metabolic changes suggestive of axonal damage in radiologically isolated syndrome 157
A rare association of myasthenia gravis and mitochondrial myopathy: a clinical, biochemical and morphologic study of one case 157
A human post-mortem brain model for the standardization of multi-centre MRI studies 156
Assessing response to interferon-β in a multicenter dataset of patients with MS 156
Right-to-left shunt in CADASIL patients: prevalence and correlation with clinical and MRI findings 155
Application of the DSM-5 Criteria for Major Neurocognitive Disorder to Vascular MCI Patients 155
The Italian Neuroimaging Network Initiative (INNI): enabling the use of advanced MRI techniques in patients with MS 155
GABA: A new imaging biomarker of neurodegeneration in multiple sclerosis? 153
Scoring treatment response in patients with relapsing multiple sclerosis 153
Peak width of skeletonized mean diffusivity (PSMD) as marker of widespread white matter tissue damage in multiple sclerosis 153
Merosin positive congenital muscular dystrophy with severe involvement of the central nervous system 152
CADASIL and cerebrovascular diseases 152
Defining brain volume cutoffs to identify clinically relevant atrophy in RRMS 152
Automated identification of brain new lesions in multiple sclerosis using subtraction images 151
Increased QT variability in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. 151
Regional cortical thinning in multiple sclerosis and its relation with cognitive impairment: A multicenter study 150
Pronounced structural and functional damage in early adult pediatric-onset multiple sclerosis with no or minimal clinical disability 150
N-acetylaspartate: usefulness as an indicator of viable neuronal tissue 149
Voxel-based assessment of differences in damage and distribution of white matter lesions between patients with primary progressive and relapsing-remitting multiple sclerosis. 149
Cognitive reserve and cortical atrophy in multiple sclerosis: A longitudinal study 149
Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study. 148
Cardiac autonomic nervous system and risk of arrhythmias in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). 148
Association of myopathy with multiple exostoses and mental retardation: a case report 145
Association of neocortical volume changes with cognitive deterioration in relapsing-remitting multiple sclerosis 145
Reproducibility of fMRI in the clinical setting: implications for trial designs 145
Retinal nerve fiber layer thinning in CADASIL: an optical coherence tomography and MRI study. 145
Towards a better understanding of pseudoatrophy in the brain of multiple sclerosis patients 145
Urgent challenges in quantification and interpretation of brain grey matter atrophy in individual MS patients using MRI 145
Modeling the distribution of new MRI cortical lesions in multiple sclerosis longitudinal studies 144
MRI criteria for MS in patients with clinically isolated syndromes 144
Pathological cut-offs of global and regional brain volume loss in multiple sclerosis 144
Adult-onset Niemann-Pick type C disease: a clinical, neuroimaging and molecular genetic study 143
Rapid benefits of a new formulation of subcutaneous interferon beta-1a in relapsing-remitting multiple sclerosis 142
The spectrum of NOTCH3 mutation and phonotype variability in fourteen Italian families with CADASIL. 140
Peripheral neuropathy in vanishing white matter disease with a novel EIF2B5 mutation 140
Genetic leukoencephalopaties with unknown metabolic pathogenesis 140
Magnetization Transfer Imaging Demonstrates a Distributed Pattern of Microstructural Changes of the Cerebral Cortex in Amyotrophic Lateral Sclerosis 139
1H-MR Spectroscopy in Traumatic Brain Injury 139
Totale 18.345
Salva come PNG Salva come JPEG
Categoria #
all - tutte 160.399
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 160.399
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205.263 0 0 0 0 0 848 855 1.227 814 751 211 557
2020/20217.676 295 814 189 636 278 847 865 1.253 772 536 701 490
2021/20225.254 333 718 429 298 259 203 316 174 264 528 663 1.069
2022/20236.907 437 358 820 999 695 1.432 113 632 830 176 257 158
2023/20244.219 228 129 336 134 120 1.199 1.510 148 27 64 48 276
2024/20254.300 313 541 794 1.169 1.053 430 0 0 0 0 0 0
Totale 50.186